Patient-derived xenografts (PDXs) are resected human tumors engrafted into mice for preclinical studies and therapeutic testing. It has been proposed that the mouse host affects tumor evolution during PDX engraftment and propagation, affecting the accuracy of PDX modeling of human cancer. Here, we exhaustively analyze copy number alterations (CNAs) in 1,451 PDX and matched patient tumor (PT) samples from 509 PDX models. CNA inferences based on DNA sequencing and microarray data displayed substantially higher resolution and dynamic range than gene expression-based inferences, and they also showed strong CNA conservation from PTs through late-passage PDXs. CNA recurrence analysis of 130 colorectal and breast PT/PDX-early/PDX-late trios confirmed high-resolution CNA retention. We observed no significant enrichment of cancer-related genes in PDX-specific CNAs across models. Moreover, CNA differences between patient and PDX tumors were comparable to variations in multiregion samples within patients. Our study demonstrates the lack of systematic copy number evolution driven by the PDX mouse host.

Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts

Giordano, Jessica;Galimi, Francesco;Bertotti, Andrea;Isella, Claudio;Trusolino, Livio;Medico, Enzo
;
Giordano, Silvia;Corso, Simona
2021-01-01

Abstract

Patient-derived xenografts (PDXs) are resected human tumors engrafted into mice for preclinical studies and therapeutic testing. It has been proposed that the mouse host affects tumor evolution during PDX engraftment and propagation, affecting the accuracy of PDX modeling of human cancer. Here, we exhaustively analyze copy number alterations (CNAs) in 1,451 PDX and matched patient tumor (PT) samples from 509 PDX models. CNA inferences based on DNA sequencing and microarray data displayed substantially higher resolution and dynamic range than gene expression-based inferences, and they also showed strong CNA conservation from PTs through late-passage PDXs. CNA recurrence analysis of 130 colorectal and breast PT/PDX-early/PDX-late trios confirmed high-resolution CNA retention. We observed no significant enrichment of cancer-related genes in PDX-specific CNAs across models. Moreover, CNA differences between patient and PDX tumors were comparable to variations in multiregion samples within patients. Our study demonstrates the lack of systematic copy number evolution driven by the PDX mouse host.
2021
53
1
86
99
https://doi.org/10.1038/s41588-020-00750-6
adult, animal experiment, animal model, animal tissue, breast cancer, microarray, DNA sequencing engraftment, gene amplification, tumor, xenograft, tumor-related gene
Woo, Xing Yi; Giordano, Jessica; Srivastava, Anuj; Zhao, Zi-Ming; Lloyd, Michael W.; de Bruijn, Roebi; Suh, Yun-Suhk; Patidar, Rajesh; Chen, Li; Scher...espandi
File in questo prodotto:
File Dimensione Formato  
Woo etal Nat Genet 2021 accepted manuscript.pdf

Open Access dal 08/07/2021

Descrizione: Versione Post-print
Tipo di file: POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione 402.78 kB
Formato Adobe PDF
402.78 kB Adobe PDF Visualizza/Apri
Woo etal Nat Genet 2021 accepted figures.pdf

Open Access dal 08/07/2021

Descrizione: Figure articolo
Tipo di file: MATERIALE NON BIBLIOGRAFICO
Dimensione 5.34 MB
Formato Adobe PDF
5.34 MB Adobe PDF Visualizza/Apri
s41588-020-00750-6.pdf

Accesso aperto

Tipo di file: PDF EDITORIALE
Dimensione 10 MB
Formato Adobe PDF
10 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1768036
Citazioni
  • ???jsp.display-item.citation.pmc??? 87
  • Scopus 119
  • ???jsp.display-item.citation.isi??? 112
social impact